Lung Neoplasms: all 7,333 studies
Page 65 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.
- Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer ScreeningTerminatedNCT00607425
- Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung CancerCompletedNCT00603057
- Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving ErlotinibCompletedNCT00602433
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00601094Phase 1
- A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)CompletedNCT00600496Phase 1
- Genetic Susceptibility to Lung Cancer in Never SmokersActive, not recruitingNCT00597636
- Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT ScanningCompletedNCT00596310Not applicable
- Thoracic OncoGeriatric Assessment (TOGA) TrialsCompletedNCT00591981
- Quality of Life in Lung Cancer SurvivorsCompletedNCT00586937
- A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung CancerCompletedNCT00583830Phase 2
- Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
- Physical Activity and Inactivity in Lung Cancer SurvivorsCompletedNCT00582348
- NM404 as an Imaging Agent in Patients With NSCLCCompletedNCT00582283Phase 1
- Erlotinib and Sunitinib in NSCLCCompletedNCT00581789Phase 1
- Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate CancerWithdrawnNCT00581503
- Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaCompletedNCT00580320Phase 1
- Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer TumorsCompletedNCT00579852
- Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung CancerCompletedNCT00579683
- Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
- Methylated Genes in Blood as Biomarkers for Advanced Lung CancerCompletedNCT00579462
- Lung Cancer Informational Study (LCIS)CompletedNCT00579215Not applicable
- Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
- Lung Cancer Location: a RepositoryTerminatedNCT00578084
- Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung CancerStatus unknownNCT00576914Phase 3
- Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00575393Phase 1
- Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal SputumCompletedNCT00573885Phase 2
- Radiotherapy for NSCLC to a Individualized MLDCompletedNCT00573040
- Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-ScansCompletedNCT00572923
- Concurrent Chemo-radiation Form NSCLC to a Individualized MLDCompletedNCT00572325
- Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and FormoterolCompletedNCT00569712Phase 1
- Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung CancerTerminatedNCT00569296Phase 1
- Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) PatientsCompletedNCT00569114Phase 1
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung CarcinomaTerminatedNCT00568906
- Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer PatientsCompletedNCT00568282
- Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung CancerCompletedNCT00563420Not applicable
- Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before SurgeryStatus unknownNCT00563160Phase 2
- Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
- Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00559611Not applicable
- A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in ChinaCompletedNCT00559065
- Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic SurgeryCompletedNCT00558350
- Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUSCompletedNCT00556647
- WBRT & Erlotinib in Advanced NSCLC and Brain MetastasesTerminatedNCT00554775Phase 2
- Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTerminatedNCT00551733Phase 3
- AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line ChemotherapyCompletedNCT00547651Phase 3
- Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00547443Phase 1/2
- Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung CancerStatus unknownNCT00546130Phase 2
- A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung CancerCompletedNCT00544960Phase 2
- R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung CancerCompletedNCT00544596Phase 1
- Family Quality of Life Among Families With a Member Who is a Cancer PatientCompletedNCT00544336
- Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung CancerTerminatedNCT00543335Phase 1
- Performance Status During Treatment With Pemetrexed in Patients With NSCLCCompletedNCT00540241
- Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung CancerCompletedNCT00536861Phase 1
- Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation?CompletedNCT00534690Not applicable
- A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00534027Phase 1/2
- Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer ClinicCompletedNCT00533884
- BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
- Sorafenib in Resected Non-small Cell Lung CarcinomaTerminatedNCT00532025Phase 2
- Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung CancerTerminatedNCT00531076Phase 1
- Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00530205
- A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding PhaseCompletedNCT00528281Phase 1
- CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC PatientsTerminatedNCT00526643Phase 3
- Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung CancerCompletedNCT00526461Phase 1
- STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing StudyStatus unknownNCT00526396Phase 3
- Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT00522938Phase 1/2
- Phase I Cetuximab and Concurrent Radio-chemotherapyCompletedNCT00522886Phase 1
- Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-RadiationTerminatedNCT00522639Phase 3
- ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial NeoplasiaCompletedNCT00522197Phase 2
- 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation TherapyCompletedNCT00520702Phase 2
- Dalteparin in Preventing Blood Clots in Patients With Lung CancerStatus unknownNCT00519805Phase 3
- Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00517790Phase 2
- Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IVTerminatedNCT00516685Phase 2/3
- Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLCStatus unknownNCT00516100Phase 1/2
- Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.CompletedNCT00516022Phase 2
- Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00514293Phase 2
- Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary DiseaseCompletedNCT00512746Not applicable
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
- Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00510445Phase 1
- A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- BevacizumabCompletedNCT00508625Phase 2
- Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
- Thermal Signature of Patients Undergoing Radiation TherapyWithdrawnNCT00508313
- Vibration Response Imaging (VRI) in Lung Cancer PatientsCompletedNCT00506467
- ZD6474(Vandetanib) + Alimta Combo StudyCompletedNCT00506051Phase 1
- Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic SurgeryCompletedNCT00505024Not applicable
- Gene Polymorphisms and Symptoms in Lung Cancer PatientsCompletedNCT00504374
- Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung CancerStatus unknownNCT00503958
- Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line ChemotherapyCompletedNCT00503568Phase 1
- Topotecan for Irinotecan-Refractory SCLCStatus unknownNCT00502762Phase 2
- Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic SurgeryCompletedNCT00501319
- Tracking of Respiratory-Induced Tumor Motion Using Implanted FiducialsCompletedNCT00500513Not applicable
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung CancerActive, not recruitingNCT00499330
- Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00497315Phase 2
- Danish Lung Cancer Screening Trial (DLCST)Status unknownNCT00496977Not applicable
- Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
- Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal MetastasisTerminatedNCT00492843Phase 4
- Safety Study of XL999 in Adults With Non-Small-Cell Lung CancerTerminatedNCT00491699Phase 1
- Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesCompletedNCT00490659Phase 2
- Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCompletedNCT00489996Phase 2
- Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With ChemotherapyCompletedNCT00489983Phase 2
- SRS Study in Patients With Non-Small Cell Lung CancerCompletedNCT00489008Phase 2
- African American Families and Lung Cancer StudyCompletedNCT00487760